Erbez Georgia

Avg. Two Year Performance

(38%) Avg. Purchase Return
(17%) Compound
4% Avg. Sale Return
2% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return12%(6%)21%(17%)(38%)
Purchase Success Rate2 of 41 of 42 of 41 of 40 of 4
Average Sale Return(9%)(3%)(25%)18%4%
Sale Success Rate0 of 10 of 10 of 11 of 11 of 1
Drugs » Diagnostic Substances

Chief Financial Officer:

Holdings: 19.6K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Exec VP & CFO:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

CFO and Chief Business Officer:

Holdings: 115.75K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Chief Financial Officer:

Holdings: 55.81K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

$19.84K Net Amount
Buy:$19.84K$10.92
Sell:0--
Other » Other

Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--